Ustekinumab

Ustekinumab
Measuring Ustekinumab drug concentrations in patients being treated with Ustekinumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Ustekinumab allows for reliable measurement of Ustekinumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Ustekinumab immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum, and Plasma
• Reaction Time 10 mins
  
• Detection Range 0.5-20 μg/mL
  
• Indication Quantitative determination of free Ustekinumab in human whole blood/serum/plasma
  

Click